REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 81 filers reported holding REPARE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $206 | +14.4% | 16,971 | 0.0% | 0.00% | – |
| Q2 2023 | $180 | -32.1% | 16,971 | -36.9% | 0.00% | – |
| Q1 2023 | $265 | -33.1% | 26,894 | 0.0% | 0.00% | – |
| Q4 2022 | $396 | -99.8% | 26,894 | +46.7% | 0.00% | – |
| Q3 2022 | $223,000 | -99.2% | 18,327 | -99.1% | 0.00% | -100.0% |
| Q2 2022 | $27,077,000 | -8.9% | 1,935,440 | -7.3% | 0.00% | 0.0% |
| Q1 2022 | $29,738,000 | -34.9% | 2,088,345 | -3.6% | 0.00% | -25.0% |
| Q4 2021 | $45,698,000 | -9.1% | 2,166,822 | +13.1% | 0.00% | -20.0% |
| Q3 2021 | $50,275,000 | +37.1% | 1,915,973 | +62.9% | 0.01% | +66.7% |
| Q2 2021 | $36,668,000 | +2078.7% | 1,176,004 | +2044.2% | 0.00% | – |
| Q1 2021 | $1,683,000 | +191.2% | 54,847 | +225.4% | 0.00% | – |
| Q4 2020 | $578,000 | – | 16,853 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,646,657 | $31,971,617 | 17.00% |
| MPM ASSET MANAGEMENT LLC | 2,242,636 | $27,091,043 | 14.51% |
| CHI Advisors LLC | 2,966,674 | $35,837,422 | 14.20% |
| MPM BioImpact LLC | 1,639,849 | $19,809,376 | 5.29% |
| BVF INC/IL | 8,291,988 | $100,167,215 | 2.70% |
| Deep Track Capital, LP | 3,067,731 | $37,058,190 | 1.43% |
| Redmile Group, LLC | 2,404,695 | $29,048,716 | 1.38% |
| HighVista Strategies LLC | 165,173 | $1,995,290 | 0.92% |
| Orbimed Advisors | 3,322,488 | $40,135,655 | 0.85% |
| Logos Global Management LP | 500,000 | $6,040,000 | 0.81% |